Sensus Healthcare Inc risk profile
66 Stretched several inputs deteriorating together
Measured 21 October 2026 from SRTS's filed statements. Recomputed nightly.
66 (Stretched), driven by Concentration at 91, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 84 | Acute | Volatile | One-year price volatility — 64.0% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 48 | Elevated | Easing | Free-cash-flow margin — 1.2% |
| Leverage and coverage | 0 | Contained | Stable | Net debt to EBITDA |
| Competitive position | 67 | Stretched | Stable | Revenue-growth gap against peers — -48.8 percentage points |
| Concentration | 91 | Acute | Stable | Geographic concentration — 8,571 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Sensus Healthcare Inc